Top Stories

The U.S. economy is in a happy space. Incoming economic evidence is vouching for the economy's vibrancy, which ironically is leaving traders rattled. Will the Fed construe the data points as strong enough to announce a second hike in the current rate...

New Zealand will on Friday release September figures for credit card spending, highlighting a light day for Asia-Pacific economic activity. In August, card spending was down 1.4 percent on month and up 1.9 percent on year. Malaysia will provide...


With Donald Trump refusing to commit to accepting the results of the upcoming presidential election, a new Politico/Morning Consult poll found that nearly a quarter of the Republican nominee's supporters think he should challenge the results if Democratic...


Stocks turned in another relatively lackluster performance during trading on Friday, as traders focused on the latest batch of earnings news amid a quiet day on the U.S. economic front. The major averages eventually ended the session on opposite sides...


A new version of "Willy Wonka and the Chocolate Factory" is in the works from Warner Brothers. The reboot follows the 1970s era Gene Wilder classic and the Tim Burton/Johnny Depp reboot from 2005. This new version will feature a script from "Saturday...


A new study shows that caffeine does not seem to have adverse effects on individuals with irregular heartbeats. The results of the study were published online October 17 in the journal JAMA Internal Medicine. The study included 51 people with heart...

Asian-Markets2_16Oct16.jpg Asian stock markets are mostly lower on Monday as investors digested Federal Reserve Chair Janet Yellen's comments that aggressive steps may be required to address the lingering effects of the financial crisis on the U.S. economy.
Pharma-101716.jpg Abeona Therapeutics Inc. (ABEO) is slated to present top-line results of the low-dose cohort for ABO-102 in Phase 1/2 clinical trial for Sanfilippo type A patients at the Orphan Drugs and Rare Disease Congress taking place in London, UK, from October 19th through October 20th.
Asian-Markets2_17Oct16.jpg European stocks may open a tad lower on Monday after sharp gains in the previous session. While U.S. stocks ended flat to marginally higher on Friday in the wake of better-than-expected earnings reports from three big U.S. banks and Fed Chief Janet...
tesla-panasonic-101716.jpg Electric car maker Tesla Motors announced its plans to join with Japanese electronics maker Panasonic Corp. to produce photovoltaic cells and modules in Buffalo, New York. The collaboration is subject to shareholders' approval of Tesla's planned acquisition of SolarCity Corp., the rooftop solar developer controlled by Tesla's Chief Elon Musk.
DonaldTrump-Campaign1-102116.jpg Less than three weeks before Election Day, the results of a new Atlanta Journal-Constitution poll show Donald Trump and Hillary Clinton are virtually tied in Georgia. The poll showed Trump with a slim 44 percent to 42 percent lead over Clinton among likely Georgia voters, with the two-point gap well within the margin of error.
Images1-102116.jpg Former Ku Klux Klan leader David Duke has just enough support to qualify for a televised debate in Louisiana's Senate race. A survey by Raycom Media found that Duke met the 5 percent threshold needed to participate in the debate, which will be held at Dillard University, a historically black university in New Orleans.
A new study shows that caffeine does not seem to have adverse effects on individuals with irregular heartbeats. The results of the study were published online October 17 in the journal JAMA Internal Medicine. The study included 51 people with heart failure. The study was conducted by separating the people into two groups.
Nifty futures on the SGX are trading higher, indicating a positive open for the domestic markets. It's going to be a busy week of high-profile earnings results, with many top companies such as Axis Bank, Idea Cellular, Dr Reddy's Laboratories, HDFC Bank, HDFC, Hindustan Unilever, ITC, Maruti Suzuki India,...
Reynolds American Inc. (RAI) on Friday confirmed that British American Tobacco plc (BATS.L, BTI) has offered to buy the remaining 57.8 percent stake that it does not own in the US tobacco company for $47 billion. Reynolds said its board of directors will evaluate the offer, and respond accordingly to BAT, which currently owns 42.2 percent stake in Reynolds. The proposal represents an enterprise va
Shares of Cerulean Pharma Inc. (CERU) were up nearly 40% on Wednesday after the company announced a strategic collaboration with Novartis (NVS) to create nanoparticle-drug conjugates directed at up to five targets. More
Amgen (AMGN) announced that a Phase 3 study evaluating XGEVA (denosumab) versus zoledronic acid met the primary endpoint of non-inferiority in delaying the time to first on-study skeletal-related event in patients with multiple myeloma. The secondary... More
qualcomm-NXP-102116.jpg Chipmaker Qualcomm is reportedly in talks with NXP Semiconductor NV (NXPI) for a possible acquisition, reports said. According to Bloomberg, negotiations are on with a probable price of $110 t $120 per NXP share. The deal would value NXP at around $34.7 billion.
Follow RTT
Economic Calendar
10/23/16 20:30PMI ManufacturingOCT P Japan
10/23/16 19:50ExportsSEP Japan
10/23/16 19:50ImportsSEP Japan
10/23/16 19:50Trade BalanceSEP Japan
10/21/16 13:0Baker Hughes - Rig CountOCT 21 United States
10/21/16 10:0Consumer Confidence IndexOCT P Eurozone
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
01/07/17ANACCrisaborole topical ointment, 2% (NDA)FDA decision on Crisaborole for treatment of mild-to-moderate atopic dermatitis in children and adults.
01/03/17VCELMACI (BLA)FDA decision on MACI for the treatment of symptomatic cartilage defects of the knee in adult patients
12/28/16RHHBYOCREVUS (BLA)FDA decision on OCREVUS for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis
12/28/16AAAPLutathera (NDA)FDA decision on Lutathera for the treatment of gastro entero pancreatic neuroendocrine tumors
12/28/16CEMPSolithera IV (NDA)FDA decision on Solithera as a treatment for community-acquired bacterial pneumonia
Complete FDA Calendar